Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Development of molecular intervention strategies for B-cell lymphoma.

Expert review of hematology - 1 Feb 2021

Zhou Wenyujing, Chen Weihong

Abstract excerpt

INTRODUCTION: There are many genetic mutations involved in B-cell lymphomagenesis. These mutations contribute to the prognosis of B-cell lymphomas and can be used for and targeted for intervention. AREAS COVERED: This review provides an overview of targeted gene therapies for B-cell lymphoma that were newly approved or are under clinical development. These include, TP53 mutations and related pathways, such as BTK...

Topics

Join the communities discussing this publication.

Antineoplastic Agents
Lymphoma, B-Cell
Mutation
Prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33263441
DOI: 10.1080/17474086.2021.1856652

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of molecular intervention strategies for B-cell lymphoma.PMID 33263441Read ↗

Altered pathways and targeted therapy in double hit lymphomaSemantic proximity Read ↗

Drug therapy for double-hit lymphomaSemantic proximity Read ↗

Burkitt's lymphoma: molecular pathogenesis and treatment.Semantic proximity Read ↗

Diffuse large B cell lymphoma: molecular targeted therapy.Semantic proximity Read ↗

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapiesSemantic proximity Read ↗

Malignant lymphoma: pathophysiology and current therapy.Semantic proximity Read ↗

BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin LymphomasSemantic proximity Read ↗

Novel treatment for mantle cell lymphoma - impact of BTK inhibitors and beyond.Semantic proximity Read ↗

Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma.Semantic proximity Read ↗

Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Genetic lesions and targeted therapy in Hodgkin lymphomaSemantic proximity Read ↗

Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.